How are companion diagnostics changing cancer care?

Learn how health systems and cancer centers are advancing these essential tools

Quest Diagnostics: Why companion diagnostics are now essential to cancer care

Companion diagnostics and their partner therapies are changing cancer care—and patient outcomes—for the better. As precision medicine continues to evolve, health systems and community cancer centers will play a major role, connecting the dots between pharma, labs, providers, and patients.

Download this white paper to:

  • Review a brief history of companion diagnostics, including how they originated and the role of the FDA
  • Find out where companion diagnostics stand today, how they’ve improved cancer care, and what’s ahead
  • Learn how health systems and community cancer centers will advance these essential diagnostic tools

By supporting and advancing the evolution of targeted diagnostics and therapies, health systems will help ensure that more patients receive the right treatment. Learn more in “Why companion diagnostics are now essential to cancer care.”

Find out how companion diagnostics are changing cancer care.

Complete the form and click submit.
*Indicates required fields

This website uses cookies for improvement of quality and user experience. By continuing to use the site, you confirm your awareness and acceptance of our use of cookies. For more information or to opt out of the use of cookies, see our Cookies Notice.